Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
ANI Pharmaceuticals is growing into a rare-disease specialty story while still generating generics cash flow. The company reported record 2025 revenue of $883.4M (up 43.8% YoY) and is guiding to >$1B in 2026. At a market cap near $1.93B and a P/E ~21, the stock trades like a generics mid-cap despite rare-disease growth driving margin expansion and …
Nextpower Inc (NASDAQ:NXT) shares declined 4.2% on Friday after Jefferies reduced its price target to $153 from $159 while retaining a Buy rating. Jefferies analyst Julian Dumoulin-Smith cited a negative market reaction to the company's latest mergers and acquisitions and growing investor questions about strategic direction. Despite the lower price…
A Jefferies survey of 40 IT executives found Microsoft, Amazon Web Services, Palo Alto Networks and ServiceNow to be the most favored software and services providers heading into 2026. The report also highlights accelerating software budget expectations, widespread dedicated AI budgets and a notably negative read-through for Adobe amid AI-related p…
A University of Michigan survey found U.S. consumer sentiment rose in June to a final reading of 49.5 from 44.8 in May, signaling a modest recovery from recent lows. Despite the uptick, more than half of households continued to cite high prices as a drag on personal finances, and inflation expectations remain above pre-crisis norms over the next ye…
Veeva Systems (VEEV) remains one of the highest-quality vertical SaaS franchises: recurring subscription growth, strong free cash flow, and a pristine balance sheet. Recent beats and raised FY2027 guidance validate the business, but the stock has been volatile and still trades well off its 52-week peak. This trade idea offers a structured long with…
Cognition Therapeutics (CGTX) has tangible clinical progress and a clearer path to Phase 3 for CT1812 (zervimesine), supported by a $30M registered direct offering last year. At a market cap near $102M and a current price of $1.145, the stock offers upside if Phase 3 plans and regulatory interactions check boxes; downside is dominated by funding ne…
Joseph Burns Rhame III, an officer of the investment advisor for the Reaves Utility Income Fund, executed a direct purchase of 500 shares of the fund's stock on June 26, 2026. The transaction occurred at $41.20 per share, totaling $20,600. This acquisition increases his direct ownership stake in the utility-focused investment vehicle. The purchase …
Incyte Corporation stock rose after the European Medicines Agency's Committee for Medicinal Products for Human Use issued a positive opinion recommending approval of Opzelura (ruxolitinib) cream for adults with moderate atopic dermatitis when topical corticosteroids and topical calcineurin inhibitors are inadequate or inappropriate. The recommendat…
John Bolton, who served as national security adviser during President Donald Trump’s first term and has since become a prominent critic, is expected to plead guilty to charges of mishandling classified information. Under a reported plea agreement, Bolton would face a sentencing range from no prison time to up to five years, and would pay a $2.25 mi…
The Boston Beer Company’s Truly Hard Seltzer is backing the U.S. Men’s National Soccer Team with a $5 million prize for a fan if the team wins the summer tournament. The campaign, part of Truly’s 'Drink Like a Believer' initiative, includes social media contests and limited-edition product packs celebrating U.S. Soccer fandom. This marketing effort…
Capricor Therapeutics announced that the FDA's Cellular, Tissue, and Gene Therapies Advisory Committee will meet on July 29, 2026, to review the Biologics License Application for Deramiocel, an investigational cell therapy for Duchenne muscular dystrophy (DMD). The BLA is supported by positive clinical trial data from Phase 2 and Phase 3 studies sh…
Advantage Solutions Inc., a NASDAQ-listed leading omnichannel retail solutions agency, has been named the 18th largest global agency by revenue in the 2026 Ad Age Agency Report, with $1.22 billion in marketing and experiential solutions revenue. The company is the largest agency headquartered in St. Louis and continues to grow by integrating creati…
Foreign exchange option contracts across several of the major currency pairs are due to expire today at 10am ET, according to data from the Depository Trust & Clearing Corporation. Notable blocks include multi-hundred-million euro and dollar positions clustered around nearby strikes for EUR/USD, USD/JPY and others, with spot rates sitting close to …
Volkswagen ADR (VWAGY) is trading like a cyclical stock in free-fall: price near the 52-week low, technicals deeply oversold, and short activity elevated. Fundamentals say this isn't a busted carmaker — market cap is roughly $43B, P/E about 6.3 and a 5.1% yield. This trade idea frames a tactical long that accepts near-term volatility in exchange fo…
Carl Helmetag, a director at Espey Mfg & Electronics Corp (NASDAQ:ESP), executed a transaction on June 24, 2026, selling 1,015 shares of common stock at prices ranging from $63.13 to $63.98 per share, resulting in a total value of approximately $63,661. This sale reduces his direct holdings to 23,169 shares, while he retains indirect ownership of 1…
A joint survey by Citi and YouGov found that British public expectations for future inflation eased in June. Long-run expectations fell to 3.9% from 4.0% in May, while expectations for the year ahead dropped to 3.8% from 4.7%. Citi economist Callum McLaren-Stewart said the decline reduces the risk of expectations becoming deanchored and noted the m…
Qualcomm just reframed its addressable market with a doubled non-handset revenue target for 2029 and a purpose-built AI CPU. The market remains fixated on handset cycles and recent multiple compression; that creates a tactical long opportunity near $208 with well-defined risk control. This trade idea lays out an entry, stop, targets, catalysts and …
HIVE Digital Technologies Ltd. expanded a previously announced exchangeable note offering to $115 million from $100 million, priced through a subsidiary as 0% exchangeable senior notes due 2031. The move coincided with a 3.3% decline in the company’s shares on the announcement date. The notes are exchangeable into common shares at a rate equivalent…
Rocket Lab Corp. shares jumped after NASA selected the company to perform three Electron rocket launches for two science missions - PolSIR and TSIS-2 - planned to begin in early 2027. The award, part of NASA's Venture-Class Acquisition of Dedicated and Rideshare contract with a maximum aggregate value of $300 million, pushed RKLB higher in after-ho…
Aevex Corp. (NYSE: AVEX) saw its shares climb 8.4% on Friday after the company announced it will be added to the Russell 2000 Index as part of the annual reconstitution, effective after the U.S. market opens on June 29, 2026. The listing will also place Aevex in the Russell growth and value style indexes and other related size and sector indexes th…
Argus Research has begun covering Space Exploration Technologies with a Hold rating, warning that the company's unprecedented initial public offering valuation will likely require years to reconcile with more typical market multiples. While SpaceX shows robust top-line growth, the firm’s lofty price-to-sales ratio and uneven profitability profile u…
Germany’s draft budget for 2027 has been completed after Finance Minister Lars Klingbeil and cabinet colleagues agreed on ministry allocations and measures to eliminate an initial €21 billion shortfall. The gap was closed in part by drawing on a €9.7 billion reserve, and the cabinet is scheduled to approve the government draft on July 6. Officials …
Can-Fite BioPharma saw its stock climb after Japanese authorities allowed a patent application for the use of Namodenoson and related A3 adenosine receptor agonists to induce fat loss and treat obesity and metabolic disorders. The decision adds to an existing portfolio of granted patents in several countries and is supported by published scientific…
Berkeley Group Holdings PLC shares fell sharply after Berenberg reduced its rating from buy to hold, citing narrowed valuation advantage and a weaker sector outlook. The downgrade followed Berkeley’s FY2026 results and came amid the company’s demotion from the FTSE 100 to the FTSE 250. Broader market headwinds for UK housebuilders - including highe…
NOWPayments has partnered with KoinX to publish free, jurisdiction-specific Crypto Tax Educational Assets aimed at helping businesses that accept or are considering accepting cryptocurrency address tax, accounting and regulatory reporting obligations across regions including Spain, the EU, the UAE and LATAM.
